<DOC>
	<DOCNO>NCT00512707</DOCNO>
	<brief_summary>The purpose placebo-controlled study determine testosterone replacement therapy , administer transdermal gel , improve response sildenafil ( Viagra R ) treatment men erectile dysfunction ( ED ) low testosterone level .</brief_summary>
	<brief_title>Effect Testosterone Men With Erectile Dysfunction</brief_title>
	<detailed_description>This double-blind , placebo-controlled , parallel-group , randomized clinical trial men , 40-70 year age , present mild moderate erectile dysfunction androgen deficiency define serum total testosterone level 300 ng/dL , measure liquid chromatography tandem mass spectrometry , LC-MS/MS ( 15 ) and/or free testosterone level ( measured equilibrium dialysis ) 50 pg/ml . Sexual function assessment include validate erectile function questionnaire ( IIEF ) , sexual activity diary , sexual desire , partner interaction intimacy , affect balance scale , mood , ED-related quality life , penile rigidity response visual erotic stimulus . The initial assessment make prior treatment sildenafil citrate , i.e. , subject naïve withdrawn PDE5 inhibitor and/or testosterone . Participants allot three sildenafil citrate tablet per week ( 12 pill per month ) , use one tablet within 24-hour period . During Sildenafil-Dose Optimization period , subject naïve sildenafil citrate start 50 mg dose . Those used sildenafil citrate past take dose find efficacious . After three week , dose sildenafil citrate increase 100-mg non-responders . For tolerate 50-mg dose , dose 25 mg give . After three week optimize dose sildenafil citrate , subject undergo second evaluation sexual function . They randomly assign receive optimize dose sildenafil citrate either placebo gel ( 15 g per day ) active testosterone gel ( 10 g active gel + 5 g placebo gel per day ) . The daily dose active testosterone gel select increase average serum upper-half normal range healthy , young men ( e.g. , 500-1000 ng/dL ) . In order assure serum testosterone level target range ( 500-1000 ng/dL ) , testosterone dose adjust unblinded individual two three week initiation testosterone/placebo treatment , base measurement serum testosterone level . If average testosterone level less 500 ng/dL , daily dose increase 15g active gel . If average testosterone great 1,000 ng/dL , daily dose decreased 5 g active gel ( 10 g placebo gel ) . This dose adjustment take effect week 4 ( day 28 ) treatment . Subjects treat additional 12-weeks sildenafil citrate optimize dose testosterone gel placebo gel . Sexual function evaluate end treatment period .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Phosphodiesterase Inhibitors</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Men , 4070 year age , stable relationship , mild moderate erectile dysfunction least 6 month ; define IIEFEF domain score 11 25 ( mild moderate ED ) Neutral extremely dissatisfy one 's sex life Presence androgen deficiency define serum total testosterone level le 300 ng/dL ( measure LCMS/MS ) and/or free testosterone level ( measured equilibrium dialysis ) less 50 pg/ml . Able understand nature study provide write , informed consent Contraindication use testosterone , e.g. , history prostate breast cancer benign prostatic hyperplasia AUA/IPSS symptom score 21 great erythrocytosis ( hematocrit &gt; 50 % baseline ) untreated , severe sleep apnea serum PSA level &gt; 4 ug/L exclude unless urologic evaluation past three month exclude prostate cancer . Contraindication use sildenafil , e.g. , symptomatic coronary artery disease take longacting shortacting nitrate drug regular basis . Symptomatic postural hypotension Congestive heart failure class III IV symptom History myocardial infarction stroke within past six month Primary diagnosis another sexual disorder premature ejaculation AST , ALT , alkaline phosphatase elevation great three time upper limit normal , creatinine great 2 mg/dL . Currently take testosterone oral androgen precursor ; unless willing discontinue use 4 week ( oral precursor transdermal testosterone patch gel ) 6 week ( injectable testosterone ) initial screen visit . Currently take medication affect androgen metabolism , action , clearance ( dilantin , phenobarbital , aldactone , flutamide , finasteride ) . Uncontrolled diabetes mellitus diabetes mellitus , e.g. , baseline hemoglobin A1C le 8.5 % . Structural abnormality penis , include Peyronie 's disease , exclude . Men take medication erectile dysfunction , include sildenafil , must stop use medication least 4 week start Visit 2 . DSMIV criterion Axis I psychiatric disorder within past year , include depression ; use psychotropic medication least six month , dementia also exclusion .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>testosterone</keyword>
	<keyword>erectile dysfunction</keyword>
	<keyword>sildenafil</keyword>
</DOC>